𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pancreatic cancer — Adjuvant therapy

✍ Scribed by Asma Sultana; John Neoptolemos; Paula Ghaneh

Publisher
Springer
Year
2007
Tongue
English
Weight
182 KB
Volume
6
Category
Article
ISSN
1610-1979

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant therapy for pancreatic cancer :
Adjuvant therapy for pancreatic cancer : A review
✍ Dan S. Zuckerman; David P. Ryan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract Pancreatic cancer is uniformly fatal unless it can be surgically resected. Survival rates for the 15% to 20% of patients who have resectable disease, however, are a disappointing 10% to 30%, depending on the status of margins and surrounding lymph nodes. In the mid‐1980s, a landmark stu

Adjuvant and systemic therapy for pancre
Adjuvant and systemic therapy for pancreatic cancer
✍ Jeffrey W. Clark; Arvin Glicksman; Harold J. Wanebo 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Pancreatic cancer remains a major cause of mortality. Less than 5% of patients survive 5 years. No curative therapy exists for patients not surgically resectable. Although chemotherapeutic and radiation therapeutic approaches can provide palliation, they have not had a significant impact on 5-year s

The case for routine use of adjuvant the
The case for routine use of adjuvant therapy in pancreatic cancer
✍ Eugene P. Kennedy; Charles J. Yeo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract Pancreatic cancer is a devastating disease with a poor prognosis for most patients. Surgical resection remains the cornerstone of treatment, providing the only realistic hope of long‐term survival. Even with optimal surgical management, 5‐year survival averages 15% to 20% for resectable